What is Blood Cancer and Multiple Myeloma?

(HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds. A special six-gene pattern can help predict who is more likely to respond well to Venclexta (venetoclax), read more about Do You Have the Right Genes for This Multiple Myeloma Treatment?

Black Americans have historically been misrepresented in the medical industry, often subjected to unequal treatment and exclusion from medical advancements. This disparity is why it’s important for medical professionals, researchers, policymakers and advocates like Tony Newberne are important because these read more about Why This Multiple Myeloma Survivor Advocates for Clinical Trials